Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. (Q50129178)

25 February 2018

title

Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. (English)

1 reference

25 February 2018

1 reference

1 reference

Marta Valenciano

1

1 reference

25 February 2018

Esther Kissling

series ordinal

2

1 reference

25 February 2018

Bruno Christian Ciancio

series ordinal

3

1 reference

25 February 2018

Alain Moren

series ordinal

4

1 reference

25 February 2018

language of work or name

English

0 references

publication date

17 September 2010

1 reference

25 February 2018

published in

Vaccine

1 reference

25 February 2018

volume

28

1 reference

25 February 2018

issue

46

1 reference

25 February 2018

page(s)

7381-7388

1 reference

25 February 2018

Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Influenza vaccine: the challenge of antigenic drift.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Heterogeneity of influenza case definitions and implications for interpreting and comparing study results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Duration of influenza A virus shedding in hospitalized patients and implications for infection control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Contagious period for pandemic (H1N1) 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Effectiveness of influenza vaccine in the community-dwelling elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Influenza vaccination and mortality benefits: new insights, new opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Comparison of monovalent and trivalent live attenuated influenza vaccines in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Effectiveness of two pertussis vaccines in preterm Danish children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Using validation sets for outcomes and exposure to infection in vaccine field studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

On estimation of vaccine efficacy using validation samples with selection bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Estimation of influenza vaccine effectiveness from routine surveillance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Estimation of influenza vaccine effectiveness using routine surveillance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Using sentinel surveillance to monitor effectiveness of influenza vaccine is feasible: A pilot study in Denmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Low coverage of seasonal influenza vaccination in the elderly in many European countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Field investigation of influenza vaccine effectiveness on morbidity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Estimation of vaccine effectiveness using the screening method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

Real-time monitoring of the influenza vaccine field effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.010

10.1016/J.VACCINE.2010.09.010

7 January 2021

Identifiers

DOI

1 reference

25 February 2018

PubMed ID

20851086

1 reference

25 February 2018